{"id":307920,"date":"2026-10-14T14:24:13","date_gmt":"2026-10-14T08:54:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=307920"},"modified":"2026-10-16T11:15:16","modified_gmt":"2026-10-16T05:45:16","slug":"why-anthem-biosciences-share-consecutive-price-fall-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-anthem-biosciences-share-consecutive-price-fall-2026\/","title":{"rendered":"Anthem Biosciences (ANTHEM) Share Price Falls for Fourth Consecutive Session"},"content":{"rendered":"
Anthem Biosciences (ANTHEM)<\/a> share price fell to Rs 820.85 today, down 2.47% from the previous close. Market cap was Rs 47,790 crore.<\/em><\/div>\n

Anthem Biosciences Share Price Fall Streak continues in its fourth consecutive session, with the latest traded price at Rs 820.85, down Rs 20.75 or 2.47% from the previous close. The cumulative fall across the streak now stands at 7.05% from Rs 883.1, and the company\u2019s market capitalisation is Rs 47,790 crore. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established.<\/p>\n

This longer run matters because it is more informative than a single lower session. A four-session decline can change how readers interpret Anthem Biosciences Share Price Fall Streak, the relative positioning of Anthem Biosciences Share Price Today and the wider stock analysis lens around valuation, sector context and peer comparison. The business remains a large-cap name in healthcare, but the current move has shifted the conversation toward price, multiples and how the latest level compares with the recent starting point.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n